Transgene's total assets for Q2 2025 were €40.99M, a decrease of -2.81% from the previous quarter. FR:TNG total liabilities were €44.59M for the fiscal quarter, a 65.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.